Abstract #3727  -  Care and treatment program in a sub-Saharan country lessons learnt and areas of focus, Kenya 2012. El problema de la retencion (control y seguimiento a largo plazo de los pacientes bajo TARV) de los pacientes VIH+ en los paises pobres en recursos
Authors:   Presenting Author:   Dr Dr Kimanga - ad
Additional Authors:
Aim: Kenya is among top ten high HIV burden countries in the world with an estimated 1.6 million adults and children living with HIV as at December 2012. Provision of antiretroviral therapy (ART) is key in preventing early deaths and new HIV infections. We describe the scale of the ART program in Kenya since 2003
Method / Issue: Kenya rolled out antiretroviral therapy in late 2003 and these were made free in 2006. A combination of strategies have ensured that these drugs are made available to adults and children, these strategies included decentralization, task shifting combined with robust supply chain management. Mathematical modeling using EPP spectrum was used to determine impact of the ART program since inception. Lastly data from 177 health facilities with EMR were also used to estimate retention of adults and children to determine outcomes of patients on treatment
Results / Comments: By December 2012, 604,000 adults and children were on treatment with 55,439 (9.2%) being children this was an increase from 25,000 in 2004. These numbers translates to a treatment coverage of 85% for adults and 37% for children. Provision of ART has enabled the country to avert more 340, 000 early deaths and 240,000 new infections. Approximately, 64% of adults not on treatment were lost to follow-up while 10% were dead. For children 43% and 11% of those not on ART were lost to follow up and dead respectively while for those on ART only 15% and 9% were dead and lost to follow up respectively.
Discussion: Scale up of ART in Kenya has been majorly successful. Still, a lot more needs to be done to ensure children are started on treatment to improve their treatment coverage, retention and outcomes.
Go Back

Please note: This is a draft only. Not all details are shown. The details shown here are not final